Suchergebnisse - "Brouwer, Philip J.M."

PubPharm (6)

1

A Lassa virus mRNA vaccine confers protection but does not require neutralizing antibody in a guinea pig model of infection

enthalten in: Nature communications | 2023

von Ronk, A. | Lloyd, N. | Zhang, M. | +15

2

Structural conservation of Lassa virus glycoproteins and recognition by neutralizing antibodies

enthalten in: Cell reports | 2023

von Perrett, H. | Brouwer, P. | Hurtado, J. | +16

3

Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection

enthalten in: Cell host & microbe | 2022

von Brouwer, P. | Antanasijevic, A. | Ronk, A. | +21

4

Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidate

enthalten in: Nature communications | 2022

von Sliepen, K. | Radić, L. | Capella-Pujol, J. | +17

5

Antigen- and scaffold-specific antibody responses to protein nanoparticle immunogens

enthalten in: Cell reports. Medicine | 2022

von Kraft, J. | Pham, M. | Shehata, L. | +25

6

Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens

enthalten in: eLife | 2020

von Ueda, G. | Antanasijevic, A. | Fallas, J. | +22

1
[1]